Advancing our mission to accelerate therapies for pulmonary fibrosis and interstitial lung disease (PF/ILD) means bringing together the researchers, clinicians, industry professionals, and patients who are helping move promising science toward new treatment options.

​

Join Three Lakes 12-20 for a free webinar on Saturday, November 7, 2026, featuring Dr. Tanzira Zaman, who will discuss the Zinc + Nicotinamide Riboside (NR) clinical trial.

​

During this webinar, you’ll learn about the science behind the study, its design and objectives, and information for those interested in participating in the trial. You’ll also hear from a patient on the trial and have the opportunity to submit questions for an open Q&A session.

​

Be part of the conversation as we explore promising research and work toward better treatment options for people affected by PF/ILD.